| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
60,872 |
56,631 |
$25.19M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
81,360 |
76,637 |
$13.89M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
102,906 |
97,523 |
$13.74M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
215,313 |
192,819 |
$11.42M |
| G0378 |
Hospital observation service, per hour |
28,350 |
24,184 |
$8.25M |
| J9271 |
Injection, pembrolizumab, 1 mg |
861 |
688 |
$4.88M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
52,494 |
48,415 |
$3.95M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
29,193 |
27,641 |
$2.78M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
140,635 |
136,571 |
$2.49M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
141,171 |
136,961 |
$2.48M |
| 80061 |
Lipid panel |
196,633 |
193,751 |
$2.25M |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
133,971 |
131,956 |
$2.24M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
13,117 |
7,998 |
$2.14M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
3,529 |
3,446 |
$1.93M |
| 84443 |
Thyroid stimulating hormone (TSH) |
198,677 |
194,743 |
$1.93M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
25,553 |
23,959 |
$1.64M |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
100,077 |
97,318 |
$1.56M |
| 80053 |
Comprehensive metabolic panel |
259,862 |
246,318 |
$1.40M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
14,648 |
10,399 |
$1.36M |
| 71046 |
Radiologic examination, chest; 2 views |
38,053 |
36,140 |
$1.22M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
22,085 |
20,556 |
$1.22M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
33,143 |
29,441 |
$1.20M |
| 82947 |
|
63,022 |
50,967 |
$1.18M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
384,322 |
346,923 |
$1.17M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12,428 |
11,376 |
$1.14M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
5,737 |
5,614 |
$997K |
| 93975 |
|
9,982 |
9,607 |
$971K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
44,064 |
38,191 |
$948K |
| 70450 |
Computed tomography, head or brain; without contrast material |
13,330 |
12,831 |
$947K |
| 87390 |
|
70,693 |
69,700 |
$937K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
166,416 |
164,052 |
$931K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
15,691 |
15,498 |
$896K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
6,848 |
6,771 |
$817K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
30,976 |
24,707 |
$804K |
| 93458 |
|
520 |
503 |
$778K |
| 59025 |
Fetal non-stress test |
8,413 |
3,309 |
$764K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,864 |
8,655 |
$758K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
14,120 |
14,048 |
$701K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,895 |
1,960 |
$698K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,931 |
1,848 |
$693K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
26,563 |
7,671 |
$655K |
| 81514 |
|
3,647 |
3,620 |
$616K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
13,473 |
13,134 |
$608K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
22,077 |
21,278 |
$567K |
| 86702 |
|
71,221 |
70,224 |
$543K |
| 80074 |
|
20,124 |
19,893 |
$541K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
178 |
178 |
$518K |
| 82607 |
|
57,079 |
56,408 |
$508K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
23,608 |
23,312 |
$501K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
43,967 |
39,338 |
$487K |
| 86003 |
|
4,827 |
4,577 |
$470K |
| 86803 |
|
54,405 |
53,738 |
$463K |
| 86780 |
|
54,070 |
53,123 |
$461K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
21,848 |
21,666 |
$456K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
23,520 |
23,499 |
$450K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,195 |
1,160 |
$444K |
| J0897 |
Injection, denosumab, 1 mg |
402 |
390 |
$407K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
28,671 |
27,836 |
$406K |
| 76801 |
|
8,358 |
7,726 |
$406K |
| 76830 |
Ultrasound, transvaginal |
7,068 |
6,943 |
$367K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
88,927 |
85,369 |
$365K |
| 86701 |
|
71,073 |
70,134 |
$357K |
| 84439 |
|
65,799 |
64,553 |
$349K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
7,763 |
6,989 |
$346K |
| 71045 |
Radiologic examination, chest; single view |
12,253 |
11,630 |
$330K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
7,801 |
7,659 |
$320K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
411 |
383 |
$318K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,219 |
3,176 |
$307K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
733 |
718 |
$302K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
5,154 |
5,080 |
$301K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,568 |
1,555 |
$301K |
| 82728 |
|
35,859 |
35,015 |
$287K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
356 |
348 |
$276K |
| 31579 |
|
1,330 |
1,263 |
$269K |
| 86900 |
|
32,755 |
31,334 |
$259K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
9,262 |
8,999 |
$250K |
| 84702 |
|
39,342 |
34,075 |
$246K |
| 96416 |
|
1,419 |
864 |
$237K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
9,863 |
9,781 |
$234K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
125,848 |
110,597 |
$229K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
14,513 |
4,334 |
$221K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
8,039 |
7,822 |
$220K |
| 90677 |
|
2,265 |
2,259 |
$219K |
| 96367 |
|
5,246 |
3,458 |
$213K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
18,465 |
18,292 |
$207K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,503 |
2,462 |
$205K |
| 83550 |
|
39,831 |
39,043 |
$204K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
722 |
700 |
$203K |
| 83735 |
|
65,406 |
58,754 |
$194K |
| 90670 |
|
11,692 |
11,447 |
$194K |
| 87340 |
|
33,513 |
33,054 |
$190K |
| 90651 |
|
3,488 |
3,403 |
$185K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,891 |
2,807 |
$176K |
| 31231 |
|
2,071 |
2,042 |
$174K |
| 76642 |
|
4,546 |
4,246 |
$172K |
| 96415 |
|
4,043 |
2,858 |
$172K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,233 |
3,159 |
$168K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
12,486 |
12,448 |
$167K |
| 36415 |
Collection of venous blood by venipuncture |
303,320 |
273,288 |
$165K |
| 83970 |
|
7,014 |
6,719 |
$163K |
| 83540 |
|
42,246 |
41,375 |
$162K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
12,997 |
12,114 |
$159K |
| 86769 |
|
6,449 |
6,319 |
$158K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,900 |
1,547 |
$156K |
| 96417 |
|
3,992 |
2,655 |
$152K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,810 |
1,794 |
$152K |
| 97161 |
|
2,767 |
2,680 |
$150K |
| 85027 |
|
57,561 |
53,646 |
$147K |
| 76770 |
|
3,072 |
3,035 |
$143K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,963 |
3,908 |
$143K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
9,679 |
9,467 |
$141K |
| 31575 |
|
1,813 |
1,782 |
$140K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,844 |
4,674 |
$136K |
| 76536 |
|
2,696 |
2,682 |
$135K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
116 |
91 |
$135K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,275 |
5,197 |
$132K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,504 |
2,473 |
$132K |
| 93970 |
|
1,539 |
1,514 |
$131K |
| 58558 |
|
92 |
89 |
$129K |
| 87070 |
|
27,668 |
27,149 |
$129K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
5,576 |
3,197 |
$127K |
| 10060 |
|
1,765 |
1,723 |
$126K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
7,720 |
7,527 |
$125K |
| 82570 |
|
40,995 |
39,321 |
$122K |
| 84146 |
|
10,379 |
10,098 |
$121K |
| 97162 |
|
2,274 |
2,234 |
$119K |
| 83001 |
|
10,290 |
10,105 |
$116K |
| 93971 |
|
2,743 |
2,693 |
$115K |
| 81001 |
|
124,197 |
117,421 |
$115K |
| 82043 |
|
33,082 |
32,598 |
$114K |
| 82746 |
|
13,365 |
13,198 |
$113K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
637 |
628 |
$112K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
239 |
236 |
$110K |
| 84403 |
|
7,454 |
7,293 |
$110K |
| J9035 |
Injection, bevacizumab, 10 mg |
65 |
37 |
$109K |
| 82670 |
|
6,410 |
6,288 |
$109K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,850 |
1,802 |
$108K |
| 86696 |
|
9,980 |
9,853 |
$107K |
| 86762 |
|
13,300 |
13,121 |
$107K |
| 87529 |
|
3,813 |
2,902 |
$106K |
| A9270 |
Non-covered item or service |
112,442 |
88,176 |
$105K |
| 87536 |
|
2,200 |
2,159 |
$104K |
| 19083 |
|
133 |
132 |
$104K |
| 93304 |
|
406 |
383 |
$104K |
| 70496 |
|
1,476 |
1,435 |
$101K |
| 72141 |
|
914 |
905 |
$101K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,963 |
1,304 |
$101K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13,261 |
13,053 |
$100K |
| 93976 |
|
2,424 |
2,367 |
$100K |
| 20610 |
|
620 |
548 |
$100K |
| 84480 |
|
11,415 |
11,250 |
$98K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
4,448 |
1,731 |
$96K |
| 87088 |
|
23,771 |
23,149 |
$96K |
| 83002 |
|
8,541 |
8,375 |
$96K |
| 86038 |
|
13,594 |
13,388 |
$95K |
| 90686 |
|
12,294 |
12,037 |
$92K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
197 |
195 |
$91K |
| 84550 |
|
38,201 |
36,627 |
$90K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,171 |
3,691 |
$86K |
| 70491 |
|
930 |
915 |
$84K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
4,923 |
3,045 |
$82K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
56,112 |
51,024 |
$80K |
| 87077 |
|
18,542 |
18,073 |
$80K |
| 82550 |
|
22,490 |
21,072 |
$79K |
| 87186 |
|
17,807 |
17,227 |
$78K |
| 84484 |
|
31,341 |
25,937 |
$77K |
| Q3014 |
Telehealth originating site facility fee |
4,437 |
4,220 |
$77K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
4,740 |
3,536 |
$75K |
| 83880 |
|
7,489 |
7,085 |
$73K |
| 86850 |
|
32,949 |
31,602 |
$73K |
| 86706 |
|
12,848 |
12,673 |
$73K |
| 83690 |
|
35,087 |
32,880 |
$72K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
437 |
427 |
$71K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
531 |
507 |
$69K |
| 90732 |
|
671 |
634 |
$68K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
705 |
690 |
$68K |
| 77065 |
Tomosynthesis, mammo |
1,487 |
1,415 |
$68K |
| 77066 |
Tomosynthesis, mammo |
1,138 |
1,117 |
$67K |
| 86235 |
|
3,107 |
2,090 |
$66K |
| 99385 |
|
2,516 |
2,454 |
$66K |
| 83013 |
|
1,433 |
1,429 |
$66K |
| 84481 |
|
6,742 |
6,597 |
$65K |
| J9299 |
Injection, nivolumab, 1 mg |
15 |
12 |
$63K |
| 82784 |
|
6,077 |
4,961 |
$63K |
| 84144 |
|
4,858 |
4,439 |
$62K |
| 86695 |
|
8,523 |
8,413 |
$62K |
| 70486 |
|
3,465 |
3,396 |
$62K |
| 84402 |
|
4,236 |
4,171 |
$61K |
| 95819 |
|
858 |
847 |
$60K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
27 |
27 |
$60K |
| 83615 |
|
20,856 |
19,331 |
$58K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
397 |
253 |
$57K |
| 86480 |
|
1,591 |
1,582 |
$56K |
| 86140 |
|
22,209 |
20,871 |
$56K |
| 84450 |
|
23,684 |
22,698 |
$54K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
3,346 |
3,237 |
$54K |
| 93017 |
|
1,725 |
1,676 |
$54K |
| 82105 |
|
6,310 |
6,199 |
$53K |
| 84460 |
|
22,696 |
21,730 |
$53K |
| 82627 |
|
3,786 |
3,724 |
$53K |
| 73562 |
|
6,924 |
6,544 |
$52K |
| 72100 |
|
4,347 |
4,293 |
$51K |
| Q5116 |
Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg |
38 |
25 |
$51K |
| J9202 |
Goserelin acetate implant, per 3.6 mg |
494 |
471 |
$51K |
| 97165 |
|
1,593 |
1,515 |
$50K |
| 82565 |
|
25,679 |
24,096 |
$50K |
| 83020 |
|
7,035 |
6,914 |
$49K |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
4,622 |
4,581 |
$49K |
| 87081 |
|
13,838 |
13,615 |
$49K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
89 |
88 |
$48K |
| 96523 |
|
1,583 |
1,314 |
$47K |
| 96411 |
|
1,232 |
858 |
$47K |
| 87522 |
Neg quan hep c or qual rna |
1,961 |
1,926 |
$46K |
| 84100 |
|
22,525 |
20,265 |
$46K |
| 99386 |
|
1,551 |
1,526 |
$43K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
7,415 |
7,195 |
$43K |
| 96402 |
|
1,909 |
1,775 |
$43K |
| 90715 |
|
10,762 |
10,500 |
$43K |
| 73630 |
|
8,235 |
7,684 |
$42K |
| Q5126 |
Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg |
27 |
12 |
$42K |
| 88342 |
|
1,850 |
1,780 |
$41K |
| 97116 |
|
3,140 |
1,677 |
$41K |
| 82150 |
|
16,749 |
16,186 |
$41K |
| 86147 |
|
1,588 |
1,225 |
$40K |
| 99496 |
|
638 |
615 |
$40K |
| 85610 |
|
39,841 |
35,637 |
$40K |
| 90674 |
|
1,416 |
1,367 |
$39K |
| J1750 |
Injection, iron dextran, 50 mg |
309 |
256 |
$39K |
| 82747 |
|
3,951 |
3,908 |
$39K |
| 71271 |
|
695 |
695 |
$39K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
3,385 |
3,280 |
$39K |
| 82785 |
|
4,090 |
4,035 |
$39K |
| 86704 |
|
5,582 |
5,515 |
$38K |
| 86361 |
|
2,761 |
2,716 |
$37K |
| 81003 |
|
32,931 |
32,306 |
$37K |
| 96160 |
|
3,296 |
3,236 |
$37K |
| 83516 |
|
3,329 |
2,725 |
$37K |
| 80076 |
|
22,150 |
20,777 |
$37K |
| 85651 |
|
17,219 |
16,374 |
$36K |
| Q5122 |
Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg |
21 |
14 |
$36K |
| 93351 |
|
241 |
235 |
$36K |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
19 |
12 |
$36K |
| 88307 |
|
633 |
606 |
$36K |
| 86334 |
|
2,814 |
2,729 |
$35K |
| 71250 |
|
642 |
635 |
$35K |
| 86376 |
|
4,040 |
3,967 |
$35K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
10,591 |
9,710 |
$35K |
| 86225 |
|
4,408 |
4,318 |
$34K |
| 86870 |
|
761 |
706 |
$34K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,721 |
1,694 |
$34K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
2,077 |
2,074 |
$33K |
| 73610 |
|
5,813 |
5,543 |
$33K |
| 86901 |
|
32,734 |
31,315 |
$33K |
| 84520 |
|
22,627 |
21,451 |
$33K |
| 80051 |
|
16,187 |
15,515 |
$32K |
| 77080 |
|
512 |
511 |
$31K |
| 86787 |
|
4,087 |
3,980 |
$31K |
| 76818 |
|
483 |
317 |
$31K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
39 |
31 |
$31K |
| 84703 |
|
9,595 |
9,357 |
$31K |
| 95117 |
|
1,535 |
823 |
$31K |
| 11043 |
|
97 |
66 |
$31K |
| 93308 |
|
509 |
499 |
$30K |
| 93454 |
|
25 |
25 |
$30K |
| 85660 |
|
9,683 |
9,498 |
$30K |
| 86708 |
|
4,220 |
4,161 |
$29K |
| 73030 |
|
5,430 |
5,167 |
$29K |
| 86430 |
|
8,084 |
7,985 |
$29K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
18,754 |
11,807 |
$29K |
| 72110 |
|
696 |
682 |
$29K |
| 85730 |
|
29,555 |
27,527 |
$28K |
| 87480 |
|
3,244 |
3,048 |
$28K |
| 87510 |
|
3,244 |
3,048 |
$28K |
| 82378 |
|
2,659 |
2,466 |
$28K |
| 86200 |
|
3,762 |
3,716 |
$28K |
| 86592 |
|
12,129 |
11,837 |
$28K |
| 74018 |
|
2,060 |
1,957 |
$27K |
| 86160 |
|
2,591 |
2,080 |
$27K |
| 84153 |
|
2,605 |
2,562 |
$27K |
| 82533 |
|
2,670 |
2,474 |
$26K |
| 76882 |
|
660 |
629 |
$26K |
| C8930 |
Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision |
247 |
242 |
$26K |
| 87660 |
|
3,077 |
2,885 |
$25K |
| 83605 |
|
13,472 |
11,901 |
$25K |
| 86800 |
|
2,648 |
2,600 |
$25K |
| 99495 |
|
387 |
384 |
$25K |
| 73130 |
|
7,285 |
6,957 |
$24K |
| 86364 |
|
1,924 |
1,900 |
$24K |
| 86304 |
|
2,099 |
1,862 |
$23K |
| 92557 |
|
5,586 |
5,514 |
$23K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,773 |
1,760 |
$23K |
| 76641 |
|
381 |
355 |
$21K |
| 88112 |
|
903 |
890 |
$20K |
| 72040 |
|
1,719 |
1,701 |
$20K |
| 86141 |
|
2,743 |
2,704 |
$20K |
| 73502 |
|
2,381 |
2,330 |
$20K |
| 73110 |
|
3,533 |
3,293 |
$20K |
| 86258 |
|
1,302 |
1,284 |
$20K |
| 84165 |
|
3,237 |
3,145 |
$20K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
311 |
230 |
$19K |
| 74019 |
|
1,415 |
1,355 |
$19K |
| 42830 |
|
12 |
12 |
$19K |
| 85652 |
|
11,513 |
11,111 |
$19K |
| 72131 |
|
791 |
782 |
$18K |
| 97166 |
|
445 |
440 |
$18K |
| 84156 |
|
9,890 |
8,752 |
$17K |
| 84134 |
|
1,981 |
1,780 |
$17K |
| 83525 |
|
2,522 |
2,463 |
$17K |
| 87046 |
|
1,809 |
1,622 |
$17K |
| 96127 |
|
4,695 |
4,542 |
$17K |
| 86665 |
|
1,168 |
857 |
$17K |
| 84154 |
|
2,014 |
1,970 |
$16K |
| 82951 |
|
2,060 |
2,015 |
$16K |
| 86146 |
|
468 |
455 |
$16K |
| 77336 |
|
255 |
97 |
$16K |
| 82977 |
|
3,980 |
3,753 |
$16K |
| 0001A |
|
440 |
439 |
$16K |
| 93880 |
|
194 |
190 |
$16K |
| 86318 |
|
1,479 |
1,444 |
$15K |
| 83521 |
|
985 |
714 |
$15K |
| 74174 |
|
163 |
161 |
$15K |
| 99406 |
|
1,114 |
1,049 |
$15K |
| 90734 |
|
2,261 |
2,207 |
$15K |
| 29515 |
|
282 |
273 |
$15K |
| 90716 |
|
3,174 |
3,116 |
$14K |
| 70470 |
|
172 |
169 |
$14K |
| 82024 |
|
578 |
544 |
$13K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
707 |
699 |
$13K |
| 82805 |
|
3,026 |
2,781 |
$13K |
| 82465 |
|
3,352 |
3,136 |
$13K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
30,790 |
26,050 |
$13K |
| 90656 |
|
705 |
691 |
$13K |
| 86580 |
|
1,360 |
1,289 |
$12K |
| 80055 |
|
778 |
760 |
$12K |
| 90682 |
|
233 |
221 |
$12K |
| 84466 |
|
1,643 |
1,601 |
$12K |
| 82310 |
|
4,840 |
4,626 |
$12K |
| Q5108 |
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg |
16 |
12 |
$12K |
| 70487 |
|
171 |
169 |
$11K |
| 92587 |
|
83 |
83 |
$11K |
| 81025 |
|
52,519 |
49,946 |
$11K |
| 86301 |
|
990 |
934 |
$11K |
| 80197 |
|
1,327 |
1,045 |
$11K |
| 76820 |
|
3,558 |
1,720 |
$11K |
| 73080 |
|
1,974 |
1,895 |
$11K |
| 73590 |
|
3,367 |
3,092 |
$11K |
| 86765 |
|
1,537 |
1,520 |
$10K |
| 86231 |
|
1,271 |
1,266 |
$10K |
| 80164 |
|
1,636 |
1,532 |
$10K |
| 87205 |
|
5,884 |
5,658 |
$10K |
| 73700 |
|
300 |
290 |
$10K |
| 0011A |
|
287 |
285 |
$10K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
36 |
36 |
$9K |
| 82248 |
|
4,729 |
4,396 |
$9K |
| 83090 |
|
885 |
872 |
$9K |
| 82077 |
|
17,641 |
15,475 |
$9K |
| 80069 |
|
1,851 |
1,757 |
$9K |
| 70498 |
|
1,421 |
1,385 |
$9K |
| 88341 |
|
435 |
401 |
$9K |
| 83721 |
|
2,107 |
2,061 |
$8K |
| J0558 |
Injection, penicillin g benzathine and penicillin g procaine, 100,000 units |
302 |
274 |
$8K |
| 84681 |
|
744 |
732 |
$8K |
| 87045 |
|
1,578 |
1,540 |
$8K |
| 82247 |
|
3,779 |
3,503 |
$8K |
| 88304 |
|
2,129 |
2,092 |
$8K |
| 83921 |
|
695 |
691 |
$8K |
| 87102 |
|
1,817 |
1,791 |
$8K |
| 84075 |
|
4,229 |
4,092 |
$8K |
| 91320 |
|
69 |
69 |
$7K |
| 72072 |
|
656 |
645 |
$7K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
137 |
135 |
$7K |
| 86705 |
|
1,222 |
1,211 |
$7K |
| 82040 |
|
2,994 |
2,918 |
$7K |
| 85379 |
|
5,150 |
5,025 |
$7K |
| 0012A |
|
193 |
193 |
$7K |
| 74178 |
|
37 |
37 |
$7K |
| 73140 |
|
1,097 |
1,067 |
$7K |
| 74022 |
|
7,545 |
7,210 |
$7K |
| 74240 |
|
110 |
107 |
$7K |
| 82553 |
|
2,018 |
1,928 |
$7K |
| 83498 |
|
429 |
426 |
$7K |
| 84478 |
|
46 |
40 |
$7K |
| 85597 |
|
674 |
653 |
$7K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
469 |
468 |
$6K |
| 86255 |
|
971 |
919 |
$6K |
| 80177 |
|
3,729 |
3,312 |
$6K |
| 90620 |
|
722 |
709 |
$6K |
| 73552 |
|
1,319 |
1,241 |
$6K |
| 73090 |
|
2,675 |
2,489 |
$6K |
| 83010 |
|
1,020 |
966 |
$6K |
| 0002A |
|
161 |
160 |
$6K |
| 73560 |
|
949 |
865 |
$6K |
| 84445 |
|
181 |
178 |
$6K |
| 92511 |
|
78 |
77 |
$6K |
| 86703 |
|
845 |
842 |
$6K |
| 82652 |
|
383 |
382 |
$6K |
| 82330 |
|
841 |
812 |
$6K |
| 90688 |
|
434 |
416 |
$6K |
| 84425 |
|
606 |
604 |
$6K |
| 83655 |
|
1,367 |
1,361 |
$6K |
| 86735 |
|
791 |
776 |
$5K |
| 92579 |
|
627 |
618 |
$5K |
| 99383 |
|
208 |
205 |
$5K |
| 84155 |
|
2,981 |
2,920 |
$5K |
| 71101 |
|
536 |
529 |
$5K |
| 0134A |
|
177 |
177 |
$5K |
| 82140 |
|
1,393 |
1,292 |
$5K |
| 94010 |
|
312 |
295 |
$5K |
| 85045 |
|
2,987 |
2,802 |
$5K |
| 88142 |
|
380 |
376 |
$5K |
| 0071A |
|
135 |
134 |
$5K |
| 86593 |
|
1,961 |
1,922 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
33,124 |
29,542 |
$5K |
| 82952 |
|
1,990 |
1,946 |
$5K |
| 72170 |
|
4,705 |
4,586 |
$5K |
| 90661 |
|
229 |
229 |
$5K |
| 93298 |
|
273 |
273 |
$5K |
| 84112 |
|
1,381 |
1,253 |
$5K |
| 72050 |
|
105 |
104 |
$5K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
22 |
22 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
16,911 |
13,468 |
$4K |
| 99381 |
|
65 |
64 |
$4K |
| 87209 |
|
441 |
413 |
$4K |
| 0124A |
|
134 |
134 |
$4K |
| 94799 |
|
965 |
899 |
$4K |
| 99195 |
|
75 |
66 |
$4K |
| 0013A |
|
104 |
104 |
$4K |
| 94726 |
|
41 |
40 |
$4K |
| 87075 |
|
1,299 |
1,243 |
$4K |
| 86777 |
|
464 |
450 |
$4K |
| 29125 |
|
1,577 |
1,540 |
$4K |
| 73060 |
|
1,037 |
991 |
$3K |
| 92588 |
|
32 |
28 |
$3K |
| 83993 |
|
271 |
266 |
$3K |
| 84630 |
|
674 |
674 |
$3K |
| 73221 |
|
24 |
24 |
$3K |
| 72082 |
|
58 |
58 |
$3K |
| 82525 |
|
571 |
570 |
$3K |
| 85613 |
|
497 |
468 |
$3K |
| 86644 |
|
447 |
433 |
$3K |
| 99384 |
|
82 |
82 |
$3K |
| 84132 |
|
2,941 |
2,809 |
$3K |
| 86694 |
|
522 |
520 |
$3K |
| 97535 |
Self-care/home management training, each 15 minutes |
650 |
540 |
$3K |
| 85018 |
|
4,806 |
4,511 |
$3K |
| 86920 |
|
914 |
844 |
$3K |
| 86618 |
|
176 |
143 |
$3K |
| 87449 |
|
510 |
497 |
$3K |
| 73120 |
|
335 |
305 |
$3K |
| 86880 |
|
779 |
737 |
$3K |
| 70360 |
|
173 |
168 |
$3K |
| 86300 |
|
189 |
151 |
$3K |
| 69210 |
|
1,146 |
1,118 |
$3K |
| 80185 |
|
372 |
348 |
$3K |
| 90480 |
|
73 |
73 |
$3K |
| 85014 |
|
3,246 |
2,988 |
$3K |
| 81002 |
|
10,686 |
9,921 |
$3K |
| 72070 |
|
171 |
168 |
$2K |
| 84207 |
|
308 |
306 |
$2K |
| 90621 |
|
46 |
43 |
$2K |
| 86308 |
|
1,364 |
1,342 |
$2K |
| 88185 |
|
21 |
15 |
$2K |
| 80178 |
|
756 |
704 |
$2K |
| 82677 |
|
217 |
210 |
$2K |
| 89055 |
|
272 |
268 |
$2K |
| 94664 |
|
1,688 |
1,599 |
$2K |
| 10061 |
|
18 |
15 |
$2K |
| 85044 |
|
1,436 |
1,298 |
$2K |
| 86812 |
|
139 |
139 |
$2K |
| 86709 |
|
366 |
363 |
$2K |
| 87040 |
|
3,141 |
2,950 |
$2K |
| 12011 |
|
1,801 |
1,768 |
$2K |
| 87177 |
|
435 |
408 |
$2K |
| 0003A |
|
52 |
52 |
$2K |
| 85246 |
|
127 |
125 |
$2K |
| 86039 |
|
275 |
262 |
$2K |
| 85705 |
|
299 |
297 |
$2K |
| 85306 |
|
174 |
167 |
$2K |
| 99382 |
|
25 |
25 |
$2K |
| 85240 |
|
152 |
149 |
$2K |
| 0064A |
|
51 |
50 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
94 |
90 |
$2K |
| 87338 |
|
173 |
173 |
$2K |
| 82088 |
|
116 |
111 |
$2K |
| 86036 |
|
221 |
221 |
$2K |
| 73600 |
|
278 |
250 |
$2K |
| 87428 |
|
92 |
86 |
$2K |
| 83695 |
|
190 |
189 |
$2K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
4,591 |
3,465 |
$2K |
| J3480 |
Injection, potassium chloride, per 2 meq |
3,705 |
2,751 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
4,526 |
3,654 |
$2K |
| J2060 |
Injection, lorazepam, 2 mg |
9,096 |
7,219 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
3,607 |
3,287 |
$2K |
| 80202 |
|
104 |
63 |
$2K |
| 92523 |
|
14 |
14 |
$2K |
| 92520 |
|
44 |
39 |
$2K |
| 86336 |
|
217 |
210 |
$1K |
| 86778 |
|
147 |
146 |
$1K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
282 |
244 |
$1K |
| 81374 |
|
30 |
30 |
$1K |
| 12002 |
|
1,666 |
1,644 |
$1K |
| 85300 |
|
184 |
181 |
$1K |
| 73564 |
|
150 |
135 |
$1K |
| 82962 |
|
3,126 |
1,826 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
326 |
319 |
$1K |
| 85245 |
|
85 |
84 |
$1K |
| 83037 |
|
512 |
503 |
$1K |
| 85670 |
|
328 |
324 |
$1K |
| 94760 |
|
1,640 |
1,541 |
$1K |
| 82103 |
|
199 |
189 |
$1K |
| 12001 |
|
2,297 |
2,279 |
$1K |
| 72128 |
|
59 |
59 |
$1K |
| 86335 |
|
67 |
66 |
$1K |
| 73521 |
|
39 |
39 |
$1K |
| 84244 |
|
113 |
113 |
$1K |
| 85732 |
|
244 |
236 |
$1K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
13 |
13 |
$1K |
| 90461 |
|
418 |
418 |
$1K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
14 |
14 |
$994.75 |
| 90658 |
|
83 |
79 |
$984.89 |
| 73620 |
|
341 |
315 |
$955.49 |
| 84300 |
|
488 |
451 |
$939.48 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
8,989 |
7,878 |
$918.75 |
| 82172 |
|
73 |
73 |
$911.02 |
| 84295 |
|
643 |
627 |
$904.55 |
| 93270 |
|
55 |
54 |
$902.33 |
| 82390 |
|
237 |
230 |
$876.77 |
| 73070 |
|
157 |
147 |
$874.20 |
| 77072 |
|
15 |
15 |
$870.26 |
| 92567 |
|
6,840 |
6,724 |
$869.55 |
| 84305 |
|
116 |
116 |
$865.16 |
| 73100 |
|
161 |
140 |
$864.23 |
| 93922 |
|
24 |
24 |
$820.57 |
| 85303 |
|
82 |
82 |
$786.98 |
| 86645 |
|
84 |
83 |
$780.84 |
| 82435 |
|
549 |
532 |
$734.64 |
| 93296 |
|
52 |
52 |
$727.21 |
| 96401 |
|
23 |
12 |
$705.62 |
| 85384 |
|
443 |
418 |
$698.30 |
| 84166 |
|
65 |
64 |
$676.02 |
| 87517 |
|
26 |
25 |
$664.95 |
| 88184 |
|
15 |
15 |
$620.79 |
| 87324 |
|
131 |
131 |
$601.46 |
| 70480 |
|
13 |
13 |
$601.34 |
| 0081A |
|
18 |
17 |
$593.97 |
| 91200 |
|
12 |
12 |
$575.93 |
| 0072A |
|
15 |
15 |
$563.27 |
| 83930 |
|
351 |
328 |
$556.02 |
| 92524 |
|
12 |
12 |
$551.68 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
14 |
12 |
$542.91 |
| 97022 |
|
81 |
25 |
$519.28 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,737 |
4,631 |
$510.53 |
| 76870 |
|
1,136 |
1,099 |
$507.43 |
| 82668 |
|
72 |
72 |
$490.02 |
| 70355 |
|
26 |
25 |
$444.10 |
| 86341 |
|
33 |
29 |
$430.10 |
| 84145 |
|
403 |
394 |
$422.54 |
| 97802 |
|
49 |
48 |
$413.89 |
| 82164 |
|
84 |
84 |
$349.20 |
| 88173 |
|
67 |
67 |
$335.54 |
| 87106 |
|
49 |
47 |
$322.07 |
| 92228 |
|
39 |
39 |
$314.55 |
| 82679 |
|
31 |
30 |
$303.88 |
| J1756 |
Injection, iron sucrose, 1 mg |
3,322 |
1,883 |
$294.36 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,632 |
3,595 |
$267.06 |
| 82671 |
|
12 |
12 |
$261.12 |
| 90744 |
|
212 |
208 |
$238.30 |
| 90473 |
|
77 |
77 |
$237.60 |
| 69200 |
|
186 |
178 |
$220.99 |
| 73000 |
|
26 |
26 |
$217.17 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
942 |
737 |
$210.91 |
| 83718 |
|
39 |
39 |
$198.96 |
| 85049 |
|
79 |
77 |
$179.46 |
| 82626 |
|
14 |
14 |
$178.15 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
52 |
44 |
$177.03 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
19,538 |
18,769 |
$172.90 |
| 96376 |
|
4,577 |
4,058 |
$167.02 |
| 97035 |
|
29 |
13 |
$163.04 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15,020 |
13,631 |
$153.71 |
| 83835 |
|
12 |
12 |
$150.84 |
| 69209 |
|
82 |
75 |
$150.81 |
| 80156 |
|
26 |
24 |
$149.70 |
| 73660 |
|
13 |
13 |
$144.42 |
| 82239 |
|
42 |
41 |
$142.37 |
| 87280 |
|
17 |
17 |
$131.68 |
| 82232 |
|
15 |
15 |
$131.23 |
| 86256 |
|
14 |
14 |
$128.92 |
| J2359 |
Injection, olanzapine, 0.5 mg |
16 |
12 |
$126.48 |
| 86664 |
|
12 |
12 |
$120.53 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,442 |
1,425 |
$120.00 |
| 87076 |
|
44 |
43 |
$108.94 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
58,906 |
49,010 |
$107.86 |
| 93320 |
|
860 |
835 |
$106.00 |
| 84590 |
|
14 |
14 |
$105.60 |
| 86663 |
|
12 |
12 |
$103.50 |
| 86015 |
|
13 |
13 |
$103.37 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
10,225 |
8,277 |
$96.16 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
60 |
60 |
$82.01 |
| 93325 |
|
2,418 |
2,356 |
$80.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
20,353 |
16,255 |
$79.43 |
| 83935 |
|
26 |
26 |
$79.35 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,436 |
3,197 |
$65.34 |
| 51701 |
|
13 |
13 |
$64.79 |
| 90474 |
|
21 |
21 |
$63.30 |
| 80179 |
|
1,228 |
1,205 |
$61.83 |
| 77073 |
|
27 |
27 |
$59.64 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
850 |
426 |
$56.79 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
11,914 |
10,701 |
$56.25 |
| 80175 |
|
12 |
12 |
$55.17 |
| 80143 |
|
1,344 |
1,300 |
$54.96 |
| 90680 |
|
8,183 |
8,056 |
$53.06 |
| 82374 |
|
14 |
13 |
$49.80 |
| 90672 |
|
72 |
72 |
$48.64 |
| 96377 |
|
15 |
12 |
$47.60 |
| 90697 |
|
1,349 |
1,346 |
$46.06 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
63 |
62 |
$38.77 |
| 82375 |
|
42 |
41 |
$37.85 |
| 90723 |
|
9,105 |
8,956 |
$37.50 |
| 80305 |
|
325 |
321 |
$35.01 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
9,309 |
4,559 |
$34.69 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
561 |
552 |
$31.58 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,643 |
2,720 |
$30.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
754 |
549 |
$27.00 |
| J1643 |
Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units |
558 |
522 |
$25.05 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
18,757 |
14,410 |
$24.20 |
| J7050 |
Infusion, normal saline solution, 250 cc |
6,356 |
5,136 |
$19.23 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
368 |
352 |
$16.98 |
| J2401 |
Injection, chloroprocaine hydrochloride, per 1 mg |
14 |
13 |
$14.76 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
460 |
445 |
$13.12 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
21,914 |
18,132 |
$12.01 |
| 85347 |
|
604 |
522 |
$11.94 |
| 90647 |
|
9,178 |
9,016 |
$7.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
14,022 |
13,236 |
$6.83 |
| 81000 |
|
36 |
31 |
$6.48 |
| 96368 |
|
1,676 |
1,145 |
$6.13 |
| J1836 |
Injection, metronidazole, 10 mg |
174 |
117 |
$6.12 |
| 87015 |
|
15 |
12 |
$4.51 |
| 87206 |
|
15 |
12 |
$3.65 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
168 |
160 |
$3.23 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,288 |
1,016 |
$3.00 |
| J2704 |
Injection, propofol, 10 mg |
12,983 |
12,502 |
$2.42 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
16,623 |
15,362 |
$1.28 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
4,311 |
3,712 |
$0.93 |
| 36416 |
|
834 |
741 |
$0.06 |
| J1644 |
Injection, heparin sodium, per 1000 units |
6,829 |
4,116 |
$0.04 |
| J1630 |
Injection, haloperidol, up to 5 mg |
4,562 |
3,809 |
$0.00 |
| 90696 |
|
2,387 |
2,362 |
$0.00 |
| J3490 |
Unclassified drugs |
2,094 |
1,390 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,323 |
2,255 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,317 |
1,286 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
180 |
172 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
569 |
554 |
$0.00 |
| C1769 |
Guide wire |
2,625 |
2,497 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
289 |
248 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
144 |
110 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
5,631 |
2,857 |
$0.00 |
| 11045 |
|
286 |
151 |
$0.00 |
| 76377 |
|
1,381 |
1,353 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
1,506 |
962 |
$0.00 |
| J7121 |
5% dextrose in lactated ringers infusion, up to 1000 cc |
518 |
402 |
$0.00 |
| J9045 |
Injection, carboplatin, 50 mg |
1,139 |
753 |
$0.00 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
684 |
557 |
$0.00 |
| 99292 |
|
88 |
86 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
668 |
630 |
$0.00 |
| J9267 |
Injection, paclitaxel, 1 mg |
806 |
381 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
561 |
517 |
$0.00 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
720 |
554 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
64 |
40 |
$0.00 |
| 91301 |
|
653 |
649 |
$0.00 |
| 90632 |
|
385 |
339 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
357 |
354 |
$0.00 |
| 90619 |
|
37 |
37 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
38 |
38 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
176 |
173 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
46 |
45 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
65 |
63 |
$0.00 |
| 91307 |
|
251 |
250 |
$0.00 |
| A6022 |
Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each |
18 |
12 |
$0.00 |
| 91305 |
|
26 |
26 |
$0.00 |
| 94660 |
|
110 |
67 |
$0.00 |
| 12013 |
|
54 |
54 |
$0.00 |
| 90381 |
|
192 |
192 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
459 |
439 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
60 |
56 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
397 |
335 |
$0.00 |
| 90698 |
|
31 |
28 |
$0.00 |
| 83520 |
|
32 |
32 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
12 |
12 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
65 |
38 |
$0.00 |
| J1165 |
Injection, phenytoin sodium, per 50 mg |
85 |
51 |
$0.00 |
| 94761 |
|
1,814 |
1,668 |
$0.00 |
| 85362 |
|
73 |
69 |
$0.00 |
| 95024 |
|
13 |
13 |
$0.00 |
| 0399T |
|
14 |
12 |
$0.00 |
| 91306 |
|
25 |
25 |
$0.00 |
| C1753 |
Catheter, intravascular ultrasound |
37 |
36 |
$0.00 |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
13 |
13 |
$0.00 |
| 30901 |
|
12 |
12 |
$0.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
41 |
13 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
22 |
17 |
$0.00 |
| C1781 |
Mesh (implantable) |
15 |
15 |
$0.00 |
| 90710 |
|
2,344 |
2,312 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
1,806 |
1,762 |
$0.00 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
1,343 |
1,246 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,859 |
1,197 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
2,439 |
2,148 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
914 |
554 |
$0.00 |
| 90700 |
|
3,021 |
2,974 |
$0.00 |
| 90633 |
|
6,547 |
6,437 |
$0.00 |
| 93321 |
|
438 |
410 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
1,524 |
1,450 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
910 |
875 |
$0.00 |
| 90707 |
|
3,569 |
3,487 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,733 |
1,659 |
$0.00 |
| 76942 |
|
261 |
255 |
$0.00 |
| J9190 |
Injection, fluorouracil, 500 mg |
1,428 |
871 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,434 |
1,355 |
$0.00 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
1,609 |
1,233 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
2,370 |
2,256 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
820 |
779 |
$0.00 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
869 |
524 |
$0.00 |
| 31720 |
|
18 |
13 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
2,719 |
2,690 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
1,093 |
940 |
$0.00 |
| J2400 |
Injection, chloroprocaine hydrochloride, per 30 ml |
201 |
190 |
$0.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
38 |
26 |
$0.00 |
| 90380 |
|
90 |
90 |
$0.00 |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
115 |
51 |
$0.00 |
| A4315 |
Insertion tray with drainage bag with indwelling catheter, foley type, two-way, all silicone |
162 |
158 |
$0.00 |
| J1245 |
Injection, dipyridamole, per 10 mg |
139 |
135 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
617 |
602 |
$0.00 |
| 91313 |
|
178 |
178 |
$0.00 |
| 85060 |
|
44 |
42 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
101 |
75 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
887 |
878 |
$0.00 |
| 0042T |
|
94 |
91 |
$0.00 |
| J3489 |
Injection, zoledronic acid, 1 mg |
165 |
158 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
64 |
64 |
$0.00 |
| 91300 |
|
706 |
679 |
$0.00 |
| 94729 |
|
24 |
24 |
$0.00 |
| 91308 |
|
106 |
103 |
$0.00 |
| J3250 |
Injection, trimethobenzamide hcl, up to 200 mg |
14 |
13 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
238 |
236 |
$0.00 |
| 91312 |
|
131 |
131 |
$0.00 |
| 82731 |
|
16 |
16 |
$0.00 |
| 99152 |
|
38 |
37 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
52 |
48 |
$0.00 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
260 |
125 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
293 |
244 |
$0.00 |
| 16020 |
|
17 |
15 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
14 |
14 |
$0.00 |
| 92978 |
|
13 |
13 |
$0.00 |